Pregnancy and Neonatal Outcomes following Prenatal Exposure to Dolutegravir: Data from the European Pregnancy and Paediatric HIV Cohort Collaboration (EPPICC) (206254)

23/11/2016
02/07/2024
EU PAS number:
EUPAS16321
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

viiv-206254-protocol-redact

English (175.88 KB - PDF) View document
Study results
Study results

viiv-206254-clinical-study-report-redact

English (1.96 MB - PDF) View document
Study report
Other information